Dr. Brian Keith Fenmore, MD

Dr. Fenmore practices at Providence Cedars-Sinai Tarzana Medical Center in Tarzana, California, part of Providence Health & Services.

Dr. Fenmore's NPI, 1194834879, was assigned on August 29, 2006. Dr. Fenmore graduated from Universidad Autonoma de Guadalajara in 1982. Dr. Fenmore holds California license A043642.

Dr. Fenmore's primary practice is Providence Cedars-Sinai Tarzana Medical Center, at 18321 Clark Street, Tarzana, CA 91356 in Los Angeles County. The practice phone is (818) 881-0800.

Dr. Fenmore's primary practice is Providence Cedars-Sinai Tarzana Medical Center in Tarzana, California, part of Providence Health & Services. Dr. Fenmore is also affiliated with UCLA West Valley Medical Center. Dmand AI also links Dr. Fenmore to 2 more hospitals and 2 physician offices, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fenmore practices, 6 sites in all. Vendor and product names are available with a free account.

Obstetrics and gynecology is Dr. Fenmore's primary specialty in the NPI Registry, under taxonomy code 207V00000X. Dr. Fenmore is board certified in obstetrics & gynecology by the American Board of Obstetrics and Gynecology. Dmand AI has Dr. Fenmore's licenses on file in 2 states: California and New Jersey.

Dmand AI lists hysterectomy, menopause, ovarian cyst, pelvic prolapse, UTI and vaginal infection among the conditions Dr. Fenmore treats.

CMS data shows 1,028 Medicare services from Dr. Fenmore across 9 procedure codes in 2024, for 400 Medicare patients. Medicare paid $81,701 for them. Every service was in an office.

CMS counts 400 Medicare patients who saw Dr. Fenmore in 2024. The largest group is 65 to 74, with 211 patients. 75% of them have high cholesterol, and 64% have high blood pressure. 4% are also on Medicaid. Their average risk score is 0.83, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Fenmore's median patient age at 56, with 98% women.

In 2024, Dr. Fenmore wrote 773 Medicare Part D claims for 172 patients. 74% of them were for generic drugs. CMS names the drug for 636 of them, across 18 drugs with 11 or more claims each, at $60,890 in total drug cost. In 2023, CMS named 578 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Fenmore for performance year 2024, reported individually. Dr. Fenmore accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fenmore as offering telehealth.

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 29 general payments to Dr. Fenmore from 12 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 56% of the total. MIMEDX Group, Inc. paid the most, $600.

Dmand AI lists 2 awards for Dr. Fenmore, most recently CMS Stage 1 EHR in 2013.

Dr. Fenmore graduated from Universidad Autonoma de Guadalajara in 1982. Dr. Fenmore is a member of American College of Obstetricians and Gynecologists.

Dr. Fenmore is in network with 6 carriers, including Blue Cross Blue Shield of Michigan, Aetna and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.